Author:
Ishiguro Kaname,Kashii Tatsuhiko,Tanabe Kouichi,Endo Naoki,Sawada Koichiro,Yasuda Hatsuna,Murakami Nozomu
Publisher
Springer Science and Business Media LLC
Subject
General Earth and Planetary Sciences,General Environmental Science
Reference15 articles.
1. Wilhelm SM, Dumas J, Adnane L et al (2011) Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity. Int J Cancer 129:245–255
2. Grothey A, Van Cutsem E, Sobrero A et al (2013) Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicenter, randomised, placebo-controlled, phase 3 trial. Lancet 38:303–312
3. Sunakawa Y, Furuse J, Okusaka T et al (2014) Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics. Invest New Drugs 32:104–112
4. The Japanese Respiratory Society (2012) Guidelines for the diagnosis/treatment of drug-induced pulmonary disorder. Osaka: Medical Review p 132 (in Japanese)
5. Cooper JA Jr, White DA, Matthay RA (1986) Drug-induced pulmonary disease. Part 1: cytotoxic drugs. Am Rev Respir Dis 133:321–340
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Regorafenib;Reactions Weekly;2015-11